Neuromyelitis Optica Consortium Act
Latest action · Jan 25, 2019 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 8, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Neuromyelitis Optica Consortium Act
This bill requires the National Institutes of Health to establish, administer, and coordinate a national consortium on neuromyelitis optica (NMO), which is a neurological disease that can cause blindness and paralysis.
The consortium must
- award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO;
- assemble a panel of experts to provide guidance and recommendations on research design and protocols; and
- designate a central laboratory to collect and analyze data from this research and to make the data and analysis available to researchers.
Cosponsors
Members who signed on, in the order they did.
Actions 3
Everything that happened, newest first.
- Jan 25, 2019Referred to the Subcommittee on Health.
- Jan 8, 2019Introduced in House
- Jan 8, 2019Referred to the House Committee on Energy and Commerce.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jan 8, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.